MySLEEPWELL app for iPhone and iPad

What is the purpose of the app?

My SLEEPWELL app will provide a personalized daily data collection schedule for the sleep study, entitled “Cardiovascular Risk Assessment among Late Adolescents: Sleep Variability, Napping and Inflammatory Biomarkers”. This study including the usage of the app has been received the IRB approval (IRB#: 1231039-3) by the University of Delaware.

In the predefined timeframe for salivary melatonin collection, auto-messages will be framed to encourage compliance and embed a video instruction on saliva sampling. Push notification will be sent hourly to ensure hourly saliva sample collection within the necessary sampling window (5 hours before habitual bedtime to the actual bedtime). Participants will be encouraged to take a photo of the saliva tube when they complete each collection. Photos and data entry are automatically time stamped. which will be used to evaluate the deviance from required time points. Additionally, My SLEEP predefines timing for recording sleep diary based on habitual sleep habits and pushes notifications to collect wake up information after preset habitual wake-up time and actual bedtime before preset habitual bedtime.


Who will be enrolled in the project?

Late adolescents will be invited to participate until 75 eligible subjects are enrolled. Inclusion criteria: (a) male or female ages 18-21 years, (b) have a smartphone (i.e. iPhone) and Internet access. Exclusion criteria: (a) self-report of medical conditions that may affect sleep, (b) chronic pain or regular use of medications with substantial impact on sleep and cardio-metabolic markers and (c) pregnancy (self-reported).


Who will access and review data?

For participants using the app, we will only collect minimum data necessary to test user acceptability and feasibility of the mobile data collection app. Only participant email and username will show in the app. The mobile app will NOT store a participant’s name, birth date, sex, home address, or other personal information. Also, only the IRB approved research team can access and review user data.